CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

NCT07315087 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

SLE - Systemic Lupus Erythematosus
SSc-Systemic Sclerosis
IIM- Idiopathic Inflammatory Myopathies
ANCA Associated Vasculitis (AAV)
Connective Tissue Disease-Associated Thrombocytopenia
SLE-ITP

Interventions

BIOLOGICAL: QT-019C

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]